GLYCOSPHINGOLIPID ENRICHED MICRODOMAINS IN CANCER CELL INVASION
鞘糖脂富集癌细胞侵袭中的微结构域
基本信息
- 批准号:7610366
- 负责人:
- 金额:$ 5.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-05-01 至 2008-04-30
- 项目状态:已结题
- 来源:
- 关键词:AdhesionsAntigensBehaviorBreastBreast Cancer CellCA-15-3 AntigenCell AdhesionCell Adhesion MoleculesCell membraneCell-Cell AdhesionCellsColon CarcinomaComplexComputer Retrieval of Information on Scientific Projects DatabaseE-CadherinEndopeptidasesEthersEthyl EtherEventFundingFutureGlycosphingolipidsGoalsGrantHumanInstitutionIntegrin alpha1IntegrinsInvasiveLipidsLocalizedLocationMCF7 cellMatrix MetalloproteinasesMediatingMediator of activation proteinMembrane MicrodomainsMembrane ProteinsMolecular ProbesPathway interactionsPeptide HydrolasesPhenotypePhosphorylcholineProcessProteinsResearchResearch PersonnelResourcesSignal PathwaySignal TransductionSignaling MoleculeSourceTransducersTumor Cell InvasionUnited States National Institutes of HealthWorkanalogcancer cellglycosylationhuman BCAR1 proteinsugartumortumor progression
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The ultimate goal for understanding and combating cancer progression is to investigate mechanisms culminating in an invasive and metastatic cell phenotype. Cancer cell invasion is a highly complex and multistep process, that is characterized by altered expression levels of cell adhesion molecules and secretion of proteolytic enzymes, along with changes in expression or activities of a variety of cellular proteins in multiple branching signaling pathways. In addition, the plasma membrane contains membrane microdomains enriched in tumor-associated glycosphingolipid (GSL)-antigens, that function as mediators of cell adhesion, and in signaling molecules, providing important locations for cell signaling. Recent studies showed that tumor cell invasion often results from aberrant signaling mechanisms initiated by differential organization and clustering of GSLs and/or membrane proteins, and their assembly with signaling molecules. The synthetic ether lipid analog ET-18-OMe (1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine) was previously shown to influence invasion of human breast and colon cancer cells and is used as a molecular probe to induce cellular invasion in order to explore changes in composition, translocation and organization of crucial molecules and the possible involvement of membrane microdomains.
Our results show that reorganization, clustering and assembly of specific membrane proteins and signal transducers with glycosphingolipids in membrane microdomains are responsible for loss of cell-cell adhesion and subsequent result in increased invasiveness of MCF-7 breast cancer cells. Where loss of cell-cell adhesion was due to sterical hindrance of E-cadherin by episialin both localized in and associated with clusters of the glycosphingolipid, MSGb5, subsequent invasion resulted from activation of MSGb5-associated FAK/cSrc signaling complexes and downstream ERK, leading to increased expression and activation of MMPs. In contrast, the invasive behavior of HCT-8 colon cancer cells was initiated through clustering of integrin alpha1 subunits and the activation of associated FAK/cSrc complexes. The followed path downstream, however, appeared to be the p130Cas-JNK pathway also leading to increased expression of MMPs and did not involve specific association with glycosphingolipids. The latter results point out to the classic integrin-dependent invasion of cancer cells, initiated through clustering of integrins. In contrast, signaling towards invasion may also occur via GSLs, adhesion to the surrounding matrix mediated by the sugar moieties of glycosphingolipids resulting in GSL-dependent adhesion may then induce signaling events to alter cellular phenotype.
Future work includes exploring alterations in glycosylation of membrane proteins and membrane microdomain glycosphingolipids involved in cancer cell invasion.
该副本是利用众多研究子项目之一
由NIH/NCRR资助的中心赠款提供的资源。子弹和
调查员(PI)可能已经从其他NIH来源获得了主要资金,
因此可以在其他清晰的条目中代表。列出的机构是
对于中心,这不一定是调查员的机构。
理解和打击癌症进展的最终目标是研究最终在侵入性和转移细胞表型中的机制。癌细胞侵袭是一种高度复杂且多步的过程,其特征是细胞粘附分子的表达水平改变和蛋白水解酶的分泌,以及多种分支信号途径中多种细胞蛋白的表达或活性的变化。此外,质膜含有富含肿瘤相关的糖磷脂(GSL) - 抗原的膜微域,它们充当细胞粘附的介体和信号分子中,为细胞信号传导提供了重要的位置。最近的研究表明,肿瘤细胞的侵袭通常是由于差异组织和GSL和/或膜蛋白的聚类引发的异常信号传导机制以及它们与信号分子的组装。 The synthetic ether lipid analog ET-18-OMe (1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine) was previously shown to influence invasion of human breast and colon cancer cells and is used as a molecular probe to induce cellular invasion in order to explore changes in composition, translocation and organization of crucial molecules and the possible involvement of membrane microdomains.
我们的结果表明,在膜微区中,特定膜蛋白和信号传感器的重组,聚类和组装和信号传感器在膜微区内的糖果脂质是导致细胞细胞粘附的丧失,随后导致MCF-7乳腺癌细胞的侵袭性增加。 eScialin均因糖化蛋白对E-钙粘蛋白的静脉障碍而导致的细胞细胞粘附丧失,并且与糖磷脂的簇相关,MSGB5随后侵袭MSGB5相关的FAK/CSRC/CSRC信号传导复合物和下游ERK,导致表达和激活的表达和Activation MMMPS,引起了MSGB5相关的FAK/CSRC信号复合物。相反,HCT-8结肠癌细胞的侵入性行为是通过整合素α1亚基和相关FAK/CSRC复合物的激活而启动的。然而,下游的跟踪路径似乎是P130CAS-JNK途径,也导致MMP的表达增加,并且不涉及与糖磷脂的特定关联。 后者的结果指出了通过整联蛋白聚类引发的经典整联蛋白依赖性侵袭。相比之下,也可能通过GSL进行侵袭的信号传导,对周围基质的粘附是由糖磷脂脂的糖部分介导的,从而导致GSL依赖性粘附,然后可能引起信号事件以改变细胞表型。
未来的工作包括探索膜蛋白和膜微域糖基化糖基化糖基化的改变,涉及癌细胞侵袭的糖脂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WIM Floris Albert STEELANT其他文献
WIM Floris Albert STEELANT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WIM Floris Albert STEELANT', 18)}}的其他基金
GLYCOSPHINGOLIPID ENRICHED MICRODOMAINS IN CANCER CELL INVASION
鞘糖脂富集癌细胞侵袭中的微结构域
- 批准号:
7960230 - 财政年份:2009
- 资助金额:
$ 5.33万 - 项目类别:
GLYCOSPHINGOLIPID ENRICHED MICRODOMAINS IN CANCER CELL INVASION
鞘糖脂富集癌细胞侵袭中的微结构域
- 批准号:
7720455 - 财政年份:2008
- 资助金额:
$ 5.33万 - 项目类别:
Effect of Medicinal Plants used by Tribes on Cancer and Bacteria
部落使用的药用植物对癌症和细菌的影响
- 批准号:
7457608 - 财政年份:2008
- 资助金额:
$ 5.33万 - 项目类别:
GLYCOSPHINGOLIPID ENRICHED MICRODOMAINS IN CANCER CELL INVASION
鞘糖脂富集癌细胞侵袭中的微结构域
- 批准号:
7381755 - 财政年份:2006
- 资助金额:
$ 5.33万 - 项目类别:
GLYCOSPHINGOLIPID ENRICHED MICRODOMAINS IN CANCER CELL INVASION
鞘糖脂富集癌细胞侵袭中的微结构域
- 批准号:
7170975 - 财政年份:2005
- 资助金额:
$ 5.33万 - 项目类别:
相似国自然基金
嵌合抗原受体巨噬细胞(CAR-M)微马达的制备及其血管蜂窝网络磁驱行为机理与控制方法研究
- 批准号:52375565
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
金属硫蛋白MT1介导癌-睾丸抗原CT23影响肝癌恶性生物学行为的研究
- 批准号:81760424
- 批准年份:2017
- 资助金额:34.0 万元
- 项目类别:地区科学基金项目
甲状腺乳头状癌的免疫原性及其对生物学行为的影响研究
- 批准号:81672641
- 批准年份:2016
- 资助金额:57.0 万元
- 项目类别:面上项目
癌-睾丸抗原OY-TES-1 对脑肿瘤恶性生物学行为的影响及抗体血清学分析
- 批准号:81360374
- 批准年份:2013
- 资助金额:40.0 万元
- 项目类别:地区科学基金项目
肿瘤相关抗原CHP2对卵巢癌生物学行为的影响及其机制探讨
- 批准号:30571953
- 批准年份:2005
- 资助金额:25.0 万元
- 项目类别:面上项目
相似海外基金
OVERCOMING STROMAL BARRIERS TO THERAPEUTICS IN PANCREAS CANCER
克服胰腺癌治疗的间质障碍
- 批准号:
10682621 - 财政年份:2022
- 资助金额:
$ 5.33万 - 项目类别:
Engineering a dynamic three-dimensional in vitro platform for the investigation of human Type 1 Diabetes immunopathogenesis
设计用于研究人类 1 型糖尿病免疫发病机制的动态三维体外平台
- 批准号:
10677617 - 财政年份:2021
- 资助金额:
$ 5.33万 - 项目类别:
Engineering a dynamic three-dimensional in vitro platform for the investigation of human Type 1 Diabetes immunopathogenesis
设计用于研究人类 1 型糖尿病免疫发病机制的动态三维体外平台
- 批准号:
10460123 - 财政年份:2021
- 资助金额:
$ 5.33万 - 项目类别: